Shaanxi Kanghui Pharmaceutical Co Ltd
SSE:603139
Shaanxi Kanghui Pharmaceutical Co Ltd
SSE:603139
Price:
24.25
CNY
0.04%
Market Cap:
¥2.4B
Income Statement
Earnings Waterfall
Shaanxi Kanghui Pharmaceutical Co Ltd
Shaanxi Kanghui Pharmaceutical Co Ltd
Income Statement
Shaanxi Kanghui Pharmaceutical Co Ltd
Shaanxi Kanghui Pharmaceutical Co Ltd
Currency: CNY
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||
| Interest Expense |
2
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
4
|
6
|
6
|
7
|
8
|
8
|
13
|
14
|
13
|
21
|
23
|
29
|
35
|
35
|
35
|
38
|
0
|
0
|
|
| Revenue |
382
N/A
|
385
+1%
|
386
+0%
|
384
0%
|
367
-4%
|
383
+4%
|
379
-1%
|
383
+1%
|
376
-2%
|
388
+3%
|
399
+3%
|
433
+8%
|
431
0%
|
427
-1%
|
422
-1%
|
419
-1%
|
414
-1%
|
428
+3%
|
452
+6%
|
457
+1%
|
443
-3%
|
464
+5%
|
472
+2%
|
483
+2%
|
492
+2%
|
498
+1%
|
518
+4%
|
589
+14%
|
673
+14%
|
677
+1%
|
669
-1%
|
605
-10%
|
562
-7%
|
556
-1%
|
543
-2%
|
513
-6%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(162)
|
(169)
|
(172)
|
(167)
|
(156)
|
(175)
|
(172)
|
(180)
|
(186)
|
(199)
|
(211)
|
(232)
|
(227)
|
(231)
|
(225)
|
(221)
|
(220)
|
(225)
|
(244)
|
(252)
|
(240)
|
(261)
|
(272)
|
(282)
|
(297)
|
(310)
|
(332)
|
(410)
|
(488)
|
(497)
|
(494)
|
(436)
|
(405)
|
(407)
|
(404)
|
(388)
|
|
| Gross Profit |
219
N/A
|
215
-2%
|
214
-1%
|
217
+1%
|
211
-3%
|
208
-1%
|
207
-1%
|
202
-2%
|
190
-6%
|
189
0%
|
188
0%
|
201
+7%
|
204
+2%
|
197
-4%
|
196
0%
|
198
+1%
|
194
-2%
|
203
+4%
|
208
+3%
|
205
-2%
|
203
-1%
|
203
+0%
|
199
-2%
|
201
+1%
|
195
-3%
|
188
-4%
|
186
-1%
|
179
-4%
|
185
+4%
|
180
-3%
|
176
-2%
|
169
-4%
|
157
-7%
|
149
-5%
|
140
-6%
|
126
-10%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(143)
|
(139)
|
(138)
|
(140)
|
(142)
|
(138)
|
(140)
|
(143)
|
(137)
|
(137)
|
(139)
|
(144)
|
(158)
|
(155)
|
(151)
|
(158)
|
(158)
|
(165)
|
(177)
|
(181)
|
(184)
|
(183)
|
(178)
|
(186)
|
(198)
|
(254)
|
(253)
|
(248)
|
(183)
|
(199)
|
(212)
|
(223)
|
(217)
|
(233)
|
(229)
|
(282)
|
|
| Selling, General & Administrative |
(132)
|
(138)
|
(138)
|
(140)
|
(131)
|
(139)
|
(140)
|
(142)
|
(127)
|
(131)
|
(133)
|
(137)
|
(147)
|
(144)
|
(140)
|
(146)
|
(144)
|
(156)
|
(168)
|
(171)
|
(167)
|
(175)
|
(170)
|
(175)
|
(175)
|
(175)
|
(176)
|
(173)
|
(163)
|
(173)
|
(186)
|
(199)
|
(197)
|
(215)
|
(211)
|
(266)
|
|
| Research & Development |
(7)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
(1)
|
(6)
|
(5)
|
(6)
|
(7)
|
(6)
|
(8)
|
(8)
|
(8)
|
(9)
|
(10)
|
(11)
|
(11)
|
(9)
|
(10)
|
(11)
|
(14)
|
(10)
|
(13)
|
(13)
|
(10)
|
(10)
|
(11)
|
(10)
|
(8)
|
(7)
|
(8)
|
(9)
|
(9)
|
|
| Depreciation & Amortization |
(4)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
(1)
|
0
|
0
|
0
|
1
|
(0)
|
(1)
|
1
|
(1)
|
(1)
|
0
|
0
|
(4)
|
(3)
|
(3)
|
2
|
2
|
1
|
2
|
2
|
2
|
3
|
3
|
1
|
(66)
|
(65)
|
(64)
|
4
|
(14)
|
(16)
|
(16)
|
7
|
(10)
|
(9)
|
(8)
|
|
| Operating Income |
77
N/A
|
77
N/A
|
76
-1%
|
77
+2%
|
69
-10%
|
71
+2%
|
67
-5%
|
59
-12%
|
54
-9%
|
52
-3%
|
50
-5%
|
57
+14%
|
46
-19%
|
42
-9%
|
45
+8%
|
40
-11%
|
36
-10%
|
38
+5%
|
31
-19%
|
24
-23%
|
18
-22%
|
20
+6%
|
21
+7%
|
15
-28%
|
(3)
N/A
|
(66)
-2 402%
|
(67)
-1%
|
(69)
-2%
|
2
N/A
|
(19)
N/A
|
(36)
-90%
|
(54)
-50%
|
(60)
-11%
|
(84)
-40%
|
(89)
-6%
|
(157)
-76%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(2)
|
(2)
|
(1)
|
(1)
|
4
|
5
|
9
|
11
|
12
|
13
|
13
|
11
|
11
|
11
|
9
|
13
|
7
|
6
|
8
|
6
|
17
|
20
|
18
|
18
|
(10)
|
(12)
|
(15)
|
(25)
|
(46)
|
(53)
|
(47)
|
(57)
|
(35)
|
(65)
|
(82)
|
(74)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
4
|
0
|
(0)
|
(0)
|
(69)
|
0
|
0
|
0
|
(12)
|
0
|
(0)
|
(0)
|
(30)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
2
|
2
|
1
|
0
|
(1)
|
1
|
1
|
3
|
3
|
2
|
2
|
(1)
|
(1)
|
(2)
|
(2)
|
1
|
1
|
1
|
2
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(7)
|
(7)
|
(7)
|
(1)
|
3
|
3
|
4
|
3
|
2
|
2
|
2
|
|
| Pre-Tax Income |
77
N/A
|
77
+0%
|
76
-1%
|
78
+2%
|
73
-6%
|
75
+2%
|
78
+3%
|
71
-8%
|
68
-4%
|
69
+0%
|
65
-6%
|
70
+8%
|
56
-20%
|
52
-8%
|
53
+2%
|
51
-3%
|
44
-14%
|
45
+4%
|
40
-12%
|
32
-20%
|
39
+22%
|
39
+2%
|
39
-2%
|
33
-14%
|
(83)
N/A
|
(85)
-3%
|
(89)
-4%
|
(100)
-13%
|
(58)
+42%
|
(68)
-18%
|
(79)
-16%
|
(107)
-35%
|
(122)
-14%
|
(147)
-21%
|
(168)
-14%
|
(229)
-36%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||
| Tax Provision |
(12)
|
(12)
|
(12)
|
(12)
|
(10)
|
(11)
|
(11)
|
(10)
|
(11)
|
(11)
|
(11)
|
(12)
|
(10)
|
(9)
|
(9)
|
(8)
|
(7)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
(5)
|
(4)
|
6
|
7
|
6
|
8
|
7
|
7
|
3
|
7
|
10
|
10
|
16
|
8
|
|
| Income from Continuing Operations |
65
|
65
|
65
|
66
|
63
|
64
|
66
|
61
|
58
|
58
|
54
|
58
|
46
|
43
|
44
|
43
|
37
|
37
|
33
|
25
|
33
|
34
|
34
|
29
|
(77)
|
(78)
|
(83)
|
(92)
|
(51)
|
(62)
|
(77)
|
(100)
|
(112)
|
(137)
|
(152)
|
(221)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(2)
|
(1)
|
0
|
1
|
3
|
2
|
1
|
2
|
14
|
14
|
19
|
22
|
25
|
28
|
29
|
26
|
22
|
29
|
31
|
37
|
|
| Net Income (Common) |
65
N/A
|
65
+0%
|
65
-1%
|
66
+2%
|
63
-5%
|
64
+1%
|
66
+3%
|
60
-9%
|
56
-7%
|
56
+0%
|
52
-7%
|
55
+6%
|
43
-22%
|
39
-8%
|
40
+1%
|
40
+1%
|
34
-15%
|
36
+6%
|
33
-9%
|
26
-21%
|
36
+39%
|
36
-1%
|
35
-3%
|
31
-11%
|
(63)
N/A
|
(64)
-1%
|
(64)
-1%
|
(70)
-9%
|
(26)
+63%
|
(33)
-27%
|
(47)
-43%
|
(74)
-55%
|
(90)
-22%
|
(108)
-20%
|
(121)
-12%
|
(184)
-52%
|
|
| EPS (Diluted) |
0.87
N/A
|
0.88
+1%
|
0.72
-18%
|
0.66
-8%
|
0.69
+5%
|
0.65
-6%
|
0.66
+2%
|
0.6
-9%
|
0.56
-7%
|
0.56
N/A
|
0.52
-7%
|
0.55
+6%
|
0.43
-22%
|
0.39
-9%
|
0.39
N/A
|
0.39
N/A
|
0.34
-13%
|
0.36
+6%
|
0.33
-8%
|
0.27
-18%
|
0.37
+37%
|
0.36
-3%
|
0.35
-3%
|
0.31
-11%
|
-0.63
N/A
|
-0.64
-2%
|
-0.64
N/A
|
-0.7
-9%
|
-0.26
+63%
|
-0.33
-27%
|
-0.48
-45%
|
-0.74
-54%
|
-0.9
-22%
|
-1.08
-20%
|
-1.21
-12%
|
-1.84
-52%
|
|
Switch to:
Switch to:
See Also
Discover More
